Skip to main content

Animations

MJFF Publications

8021 - 8030 of 8808 Results
Title
Year
  • Year
  • 2013
  • 2024
  • 2023
  • 2016
  • 2019
  • 2022
  • 2009
  • 2017
  • 2017
  • 2016
  • Summary Details
    OPEN
    Title: Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.11.001
    Citation Count: 210
  • Summary Details
    OPEN
    Title: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49258-1
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00533-w
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Arm swing as a potential new prodromal marker of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26720
    Citation Count: 163
  • Summary Details
    RESTRICTED
    Title: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose
    Journal Name: Journal of Pharmaceutical and Biomedical Analysis
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356
    Citation Count: 408
  • Summary Details
    OPEN
    Title: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002
    Citation Count: 82
  • Summary Details
    OPEN
    Title: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020
    Citation Count: 51
  • Summary Details
    RESTRICTED
    Title: How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.027
    Citation Count: 162
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.